
Zai Lab Limited ZLAB
$ 19.97
6.39%
Quarterly report 2025-Q3
added 11-06-2025
Zai Lab Limited Total Inventories 2011-2026 | ZLAB
Annual Total Inventories Zai Lab Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.9 M | 44.8 M | 31.6 M | 19 M | 13.1 M | 6 M | 3.82 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 44.8 M | 3.82 K | 22.1 M |
Quarterly Total Inventories Zai Lab Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.1 M | 61.7 M | 53.1 M | 39.9 M | 39.5 M | 41.8 M | 37.9 M | 44.8 M | 44.2 M | 36.4 M | 38.4 M | 31.6 M | 29.1 M | 23.3 M | 20.3 M | 19 M | 12.5 M | 11.1 M | 12.6 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 6 M | 889 K | - | - | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 67.1 M | 4 K | 27.8 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amarin Corporation plc
AMRN
|
259 M | $ 14.81 | -0.34 % | $ 6.04 B | ||
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.79 | -7.27 % | $ 4.31 M | ||
|
Biogen
BIIB
|
2.17 B | $ 195.63 | 0.06 % | $ 28.7 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Bristol-Myers Squibb Company
BMY
|
2.69 B | $ 60.51 | 1.12 % | $ 123 B | ||
|
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | ||
|
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.41 | 1.81 % | $ 360 M | ||
|
Amneal Pharmaceuticals
AMRX
|
612 M | $ 14.8 | 1.13 % | $ 4.57 B |